The Future of Cancer Care
Tackling the Burden of a Life-Threatening Disease
The global cost of cancer is expected to soar to an astonishing $25.2 trillion globally from 2020 to 2050, with the greatest financial burdens being felt in low- and middle-income countries. What is needed to mitigate the human and economic costs of cancer, while simultaneously ensuring that equitable treatment is a reachable goal for all?
Against the 10th anniversary of the Burjeel Holdings Oncology Conference, join Foreign Policy, in partnership with Burjeel Holdings, to hear from medical professionals, researchers, and policy makers and delve into the comprehensive policies and innovative finance models that could improve research, clinical trials, and manufacturing for cancer care affordability and alleviate the global economic burden of the disease.
Through this series of discussions, explore a future where cancer is manageable, if not entirely curable, and where access to life-saving treatment is universal.